Dave Denton is leaving Pfizer on August 15 to return to the consumer goods industry. That's the entire story. A finance chief is switching industries because he wants to.
Pfizer announced this on Thursday like it mattered to anyone who isn't Dave Denton's mother or the guy who has to post his job on LinkedIn. The stock will move or it won't. Technical analysts will draw their little triangles regardless. The 200-day moving average doesn't care that Dave prefers selling laundry detergent to selling vaccines.
Consumer goods. That's where Denton came from originally and that's where he's going back. He spent a few years counting Pfizer's money and decided he'd rather count Procter & Gamble's money or Unilever's money or whoever else sells soap and granola bars. Can't blame him. Consumer goods companies don't get congressional hearings about their pricing. They just charge you seven dollars for organic peanut butter and you pay it.
Retail traders are already panic-searching "what does CFO do" and "is this bullish." The answer is a CFO does finance and no this is not bullish or bearish it's just a guy leaving a job. But some kid in Ohio will see this headline and liquidate his three shares of PFE because he thinks the whole company is about to collapse without Dave Denton's pivot tables.
Pfizer will hire another CFO. That person will also have a name and a resume. The chart will look exactly the same. Support and resistance levels don't resign to pursue other opportunities.
Denton's last day is August 15 which gives him almost two months to finish his spreadsheets and delete his browser history. Then he'll go sell shampoo or crackers or whatever and Pfizer will keep making billions of dollars with or without him because that's how pharmaceutical companies work.
The moving averages remain undefeated and unbothered by executive turnover.
Photo by on Unsplash
Leave a Comment